SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001358403-17-000029
Filing Date
2017-02-01
Accepted
2017-02-01 16:10:13
Documents
3
Period of Report
2017-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_148598339603246.html 3  
1 FORM 3 wf-form3_148598339603246.xml 3 1780
2 RICHARD A FAIR POWER OF ATTORNEY 2-1-2017 bellicum-section16powero.htm EX-24 4101
3 RICHARD A FAIR POWER OF ATTORNEY 2-1-2017 JPG bellicum-section16powero001.jpg GRAPHIC 212274
  Complete submission text file 0001358403-17-000029.txt   299996
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Fair Richard A. (Reporting) CIK: 0001695851 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 17565033